Concourse Financial Group Securities’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3087 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4542 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4530 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4569 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4576 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 4516 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 4459 |
|
|
2023
Q2 | – | Sell |
-2,576
| Closed | -$67.2K | – | 4396 |
|
|
2023
Q1 | $67.2K | Buy |
2,576
+46
| +2% | +$1.2K | 0.01% | 984 |
|
|
2022
Q4 | $69.4K | Sell |
2,530
-923
| -27% | -$25.3K | 0.01% | 949 |
|
|
2022
Q3 | $83K | Buy |
3,453
+626
| +22% | +$15K | 0.01% | 786 |
|
|
2022
Q2 | $75K | Buy |
+2,827
| New | +$75K | 0.01% | 921 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4037 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 4120 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4046 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3929 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3843 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3757 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3604 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3504 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3512 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3469 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3203 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3500 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3470 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3351 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2964 |
|